Northwire Canada EditionThursday, July 23, 2026
Sign inSubscribe
Northwire
⌕
VZZ 0.180 +2.9% BMR 0.145 +3.6% NVO 0.055 −8.3% PMET 4.47 +2.0% CTG 0.125 +13.6% AVU 0.040 +0.0% SGML 14.32 −3.1% WRLG 0.720 +1.4% CAN 0.065 +8.3% ABRA 15.63 +1.6% LSTR 0.060 +0.0% OLA 13.10 +2.5% EQX 13.15 +2.7% SRA 0.780 +0.0% UTWO 0.390 −13.3% IVN 10.64 −1.2% VZZ 0.180 +2.9% BMR 0.145 +3.6% NVO 0.055 −8.3% PMET 4.47 +2.0% CTG 0.125 +13.6% AVU 0.040 +0.0% SGML 14.32 −3.1% WRLG 0.720 +1.4% CAN 0.065 +8.3% ABRA 15.63 +1.6% LSTR 0.060 +0.0% OLA 13.10 +2.5% EQX 13.15 +2.7% SRA 0.780 +0.0% UTWO 0.390 −13.3% IVN 10.64 −1.2%

Healthcare

Page 131
  1. Aug 29, 2025 · 08:00 · AIDR

    Rocket Doctor AI Reports First Revenues in Q2, 2025 Following Acquisition

    Rocket Doctor AI Reports First Revenues in Q2, 2025 Following Acquisition

    01
  2. Aug 29, 2025 · 07:15 · ASG

    Aurora Spine Corporation Announces Record Second Quarter Financial Results

    Aurora Spine Corporation Announces Record Second Quarter Financial Results

    02
  3. Aug 29, 2025 · 07:00 · CNVI

    Conavi Medical Reports Fiscal Q3 2025 Interim Results and Operational Highlights

    Conavi Medical Reports Fiscal Q3 2025 Interim Results and Operational Highlights

    03
  4. Aug 28, 2025 · 19:58 · HEM

    Hemostemix arranges payment plans for VesCell treatment

    Hemostemix arranges payment plans for VesCell treatment

    04
  5. Aug 28, 2025 · 18:12 · RKV

    Rakovina Therapeutics Announces Three-Month Q2 ended June 30, 2025 Financial Results and Provides Corporate Update

    Rakovina Therapeutics Announces Three-Month Q2 ended June 30, 2025 Financial Results and Provides Corporate Update

    05
  6. Aug 28, 2025 · 17:43 · UDOC

    Unidoc Health files annual financial statements

    Unidoc Health files annual financial statements

    06
  7. Aug 28, 2025 · 17:05 · KNE

    Kane Biotech Announces Second Quarter 2025 Financial Results

    Kane Biotech Announces Second Quarter 2025 Financial Results

    07
  8. Aug 28, 2025 · 08:15 · NRX

    NurExone Biologic Inc. Announces Second Quarter 2025 Financial Results

    NurExone Biologic Inc. Announces Second Quarter 2025 Financial Results

    08
  9. Aug 27, 2025 · 17:27 · PHRM

    Pharmather Holdings advances KETARx after FDA approval

    Pharmather Holdings advances KETARx after FDA approval

    09
  10. Aug 27, 2025 · 16:49 · QIPT

    Quipt receives another unsolicited offer from Forager

    Quipt receives another unsolicited offer from Forager

    10
  11. Aug 26, 2025 · 20:25 · HEM

    Hemostemix begins face-to-face sales program in Florida

    Hemostemix begins face-to-face sales program in Florida

    11
  12. Aug 26, 2025 · 19:25 · OTC

    Ocumetics completes lens exam one week postop

    Ocumetics completes lens exam one week postop

    12
  13. Aug 26, 2025 · 18:48 · VPT

    Ventripoint arranges $5M financing of debenture units

    Ventripoint arranges $5M financing of debenture units

    13
  14. Aug 26, 2025 · 17:24 · PHRM

    Pharmather Holdings hoping for big things from KETARx

    Pharmather Holdings hoping for big things from KETARx

    14
← Newer Older →